Microvascular complications - DiabetesontheNet

GLP-1 receptor agonists have a wide range of benefits

12 Dec 2019

Early blood pressure control reduces atherosclerotic event risk

12 Dec 2019

Visual impairment linked to mortality in diabetes

Investigators were aware that visual acuity loss is a common consequence of type 2 diabetes and may complicate diabetes self-management. They investigated patients with newly-diagnosed type 2 diabetes to assess whether loss of visual acuity was an independent risk factor for mortality in this population. They found that impaired visual acuity at diagnosis was associated with increased all-cause mortality, independent of other risk factors for mortality.

24 Nov 2019

Diabetes Distilled: Blood pressure variability linked to cardiovascular outcomes in diabetes

Increased risk of major cardiovascular events predicted by long-term systolic blood pressure variability.

21 Nov 2019

Controversial metformin recommendations in new ESC guidance

The latest European Society of Cardiology guidelines on diabetes, pre-diabetes and cardiovascular diseases recognise that considerable emerging evidence should have implications for daily clinical practice. Controversially, metformin is no longer recommended as first-line treatment in type 2 diabetes. Suggestions for the prevention of cardiovascular disease, advice on lifestyle intervention, new lipid and blood pressure targets, a novel approach to glucose-lowering treatment, diabetes treatment aimed at reducing heart failure risk, and cardiovascular risk management are included. The guidance has been developed in collaboration with the European Association for the Study of Diabetes and updates recommendations made in 2013.

12 Nov 2019

Blood pressure variability linked to CV outcomes in diabetes

Blood pressure variability (BPV) is considered a novel risk factor for cardiovascular disease, as clinical trials have confirmed that short- and long-term variations in blood pressure independently contribute to target organ damage, cardiovascular events and mortality. In this systematic review and meta-analysis, investigators examined the relationship between BPV and all-cause mortality, major adverse cardiovascular events, microvascular complications and organ damage in type 2 diabetes. They found that in adults with type 2 diabetes, systolic BPV was associated with adverse outcomes and concluded that variation in blood pressure provided information beyond mean blood pressure on the risk of cardiovascular disease in these individuals.

12 Nov 2019

Diabetes Distilled: Retinopathy differentiates nephropathy type but not severity in diabetes

Retinopathy is helpful in diagnosing diabetic nephropathy in type 2 diabetes.

29 Oct 2019

Polypharmacy increases complications and mortality in older people

24 Sep 2019

Peripheral neuropathy reduces muscle strength in men with diabetes

24 Sep 2019

SGLT2 inhibitors – moving on with the evidence

An updated review of the benefits and difficulties associated with the use of SGLT2 inhibitors.

17 Jul 2019

Keeping abreast of the latest diabetes research: Late-onset type 1 diabetes, sleep apnoea and driving with diabetic neuropathy

Too busy to keep up to date with the latest research? Trisha Dunning, Chair in Nursing at Deakin University and Barwon Health, Australia, selects the latest papers of interest to diabetes nurses.

29 May 2019

CREDENCE trial shows renoprotective effect of canagliflozin

Results of the CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation) trial have been published in the New England Journal of Medicine, demonstrating a 30% reduction in renal outcomes with canagliflozin compared with placebo in people with type 2 diabetes and chronic kidney disease (CKD).

17 Apr 2019

The diabetes review: A guide to the basics

A guide for non-diabetes-specialist staff on the diabetes clinical review, related to the 15 healthcare essentials advocated by Diabetes UK.

14 Feb 2019

Keeping abreast of the latest diabetes research: Pre-pregnancy care, flash monitoring, and glucose levels and mortality

Too busy to keep up to date with the latest research? In this series, Julie Brake, A DSN in Liverpool, selects the latest papers of interest to diabetes nurses.

10 Dec 2018

Bariatric surgery reduces microvascular outcomes in diabetes

Bariatric surgery improves glycaemic control and may modify cardiovascular risk in type 2 diabetes (T2D), but less is known about microvascular outcomes. Researchers performed a cohort study to examine the relationship between bariatric surgery and microvascular complications from T2D. All participants had T2D, and those who had bariatric surgery were matched with a control group who had not had the procedure. These cohorts were followed for up to 7 years, at the end which the incidence of microvascular disease was lower in the bariatric surgery group.

1 Oct 2018

Report from the IDF Congress 2017

The highlights of the recent international congress, including the latest developments in diabetes clinical practice.

8 Mar 2018

Metformin treatment in people with T2D and chronic kidney disease

Metformin is the first-line drug of choice in the treatment of type 2 diabetes in most diabetes guidance. Last year the European Medicines Agency (EMA) altered the restrictions on metformin use in people with diabetes and researchers wanted to discover, in the absence of prospective safety and efficacy studies, what was a safe, effective dose regimen for metformin in moderate and severe chronic kidney disease (CKD). Investigators concluded that metformin appeared to be safe, provided that there was dose adjustment for renal function. It was also found to be efficacious in moderate-to-severe CKD.

22 Feb 2018

Studies that changed clinical practice. Steno-2: Multifactorial intervention in type 2 diabetes and microalbuminuria

13 Sep 2017